PP
PASG icon

PDT Partners’s Passage Bio PASG Stock Holding History

PDT Partners’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,226
Closed -$76K – 1103
2022
Q1 		$76K Buy
1,226
+572
+87% +$47.1K 0.01% 885
2021
Q4 		$83K Buy
654
+109
+20% +$17.8K 0.01% 831
2021
Q3 		$108K Sell
545
-42
-7% -$10K 0.01% 732
2021
Q2 		$156K Buy
+587
New +$182K 0.01% 734

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PDT Partners's PASG Position: Q2 2022 in Review

PDT Partners sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 1,226 shares — an estimated $76K sold.

PDT Partners first reported a position in PASG in Q2 2021 and held it in 4 quarters. The position peaked at $156K in Q2 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • PDT Partners reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • PDT Partners sold 1,226 Passage Bio shares in Q2 2022, an estimated $76K.
  • PDT Partners first reported a position in Passage Bio in Q2 2021 and held it in 4 quarters.
  • PDT Partners's Passage Bio position peaked at $156K in Q2 2021.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.